Lipella Pharmaceuticals Inc. Deferred Tax Assets, Operating Loss Carryforwards
Lipella Pharmaceuticals Inc. (LIPO) had Deferred Tax Assets, Operating Loss Carryforwards of $1.79 million as of 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2025-03-28
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $1.79M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $1.16M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $1.38M.
- 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards $855.22K.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2024-12-31 | $1.79M 10-K · filed 2025-03-28 |
| 2023-12-31 | $1.16M 10-K · filed 2025-03-28 |
| 2022-12-31 | $1.38M 10-K · filed 2024-02-27 |
| 2021-12-31 | $855.22K 10-K · filed 2023-03-31 |